ATP1A1 and epilepsy: ATP1A1-associated neurological diseases have been reported in 42 individuals from seven families with symptoms compatible with Charcot–Marie–Tooth syndrome (15) and three nonrelated children with a mutation associated with epilepsy of varying severity and hypomagnesemia (16).